Back to calendar
AbCellera Biologics Inc. (ABCL) Earnings
ABCL reports earnings on Monday, November 9, 2026
earnings report
November 9, 2026 · After Market Close
Q3 2026
Est. EPS: $-0.18
Actual EPS: $-0.18
EPS surprise: -9.76%
Company overview
Market Cap$3.8B
PriceUSD 11.80
EPS (TTM)-0.54
52-week high15.02
52-week low2.75
SectorHealth Technology
IndustryBiotechnology
Employees562